Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

6.610 -0.370 (-5.30%)
Streaming Delayed Price Updated: 12:56 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
From Quanterix Corporation
Via Business Wire
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
From Quanterix Corporation
Via Business Wire
Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine
From Quanterix Corporation
Via Business Wire
Quanterix Corporation (QTRX) Q3 2021 Earnings Call Transcript
QTRX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Quanterix Corporation Releases Operating Results for Third Quarter of 2021
From Quanterix
Via Business Wire
Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021
From Quanterix
Via Business Wire
45 Biggest Movers From Yesterday
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP... 
Via Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after... 
Via Benzinga
Why Shares of Quanterix Are Climbing This Morning
Regulators are helping accelerate an early test for Alzheimer's disease. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (... 
Via Benzinga
15 Stocks Moving in Tuesday's Pre-Market Session
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted... 
Via Benzinga
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
From Quanterix Corporation
Via Business Wire
FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label
The FDA has expanded the Emergency Use Authorization (EUA) label for Quanterix Corporation's (NASDAQ: QTRX) Simoa SARS-CoV-2 N Protein Antigen Test. The... 
Via Benzinga
Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
From Quanterix Corporation
Via Business Wire
Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings”
From Quanterix Corporation
Via Business Wire
Return On Capital Employed Insights For Quanterix
Benzinga Pro data, Quanterix (NASDAQ:QTRX) reported Q2 sales of $25.37 million. Earnings fell to a loss of $13.67 million, resulting in a 39.63% decrease from last quarter. In Q1... 
Via Benzinga
Why Cassava Sciences Is Plunging Again Today
More red flags are emerging for this troubled Alzheimer's biotech company. 
Via The Motley Fool
Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations
The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again. 
Via Investor's Business Daily
Why Cassava Sciences Stock Investors Are Pulling Back
The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of... 
Via Benzinga
Quanterix Releases Statement
From Quanterix Corporation
Via Business Wire
63 Biggest Movers From Yesterday
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11... 
Via Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,... 
Via Benzinga
Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021
From Quanterix Corporation
Via Business Wire
Quanterix Corporation Releases Operating Results for Second Quarter of 2021
From Quanterix Corporation
Via Business Wire
Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
From Quanterix Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.